News

May 30, 2018May 30, 2018

Thetis Awarded $1.9M NIH Grant to Advance TP-252 into Clinical Trials for Ulcerative Colitis

News

Thetis Pharmaceuticals recently received a $1.9 million fast-track Small Business Innovation Research grant from the National Institutes of Health (NIH) to help advance the development of TP-252, an investigational oral therapy for ulcerative ... Read more

May 25, 2018May 25, 2018

IBD Research Teams Invited to Apply for Rainin Foundation’s Synergy Awards

News

The Kenneth Rainin Foundation is now accepting proposals for its Synergy Awards program, which provides up to $300,000 to teams collaborating across disciplines to advance the study and understanding of ... Read more

May 23, 2018May 23, 2018

Projects Aim to Improve Decision-making, Communication Between IBD Patients, MDs

News

The Crohn’s and Colitis Foundation, the American Gastroenterological Association (AGA) and Pfizer recently presented the results of a request for proposals to devise interventions aimed at improving shared decision-making and ... Read more

May 21, 2018May 21, 2018

Immuron’s IMM-124E Significantly Eases Symptoms of Chronic Colitis in Mouse Model, Company Reports

News

Immuron’s investigational therapy IMM-124E significantly reduced intestinal inflammation in mice models of chronic colitis, the company reports. These results add to previous preclinical evidence showing the therapy to also of benefit ... Read more

May 18, 2018May 18, 2018

Mitochondrial DNA in IBD Patients A Potential Therapeutic Target, Study Suggests

News

Patients with inflammatory bowel disease (IBD) have higher levels of inflammatory mitochondrial DNA (mtDNA) in the blood, which correlate with disease flare-ups and severity, a study reports. Researchers say these findings ... Read more

May 14, 2018May 14, 2018

OSE Immunotherapeutics Presents Promising New Data on OSE-127’s Potential to Treat IBD

News

OSE Immunotherapeutics presented new preclinical results on its investigational therapy candidate OSE-127, further validating its potential for the treatment of inflammatory bowel diseases (IBD). Results were presented in an abstract titled, ... Read more

May 11, 2018May 11, 2018

PredictImmune Awarded £4.3M to Evaluate Ability of Prognostic Test to Guide Crohn’s Treatment

News

PredictImmune has received a £4.3 million (US$5.85 million) grant to fund a prospective clinical trial to determine if its prognostic biomarker test can help personalize treatment strategies for patients with Crohn’s ... Read more

May 9, 2018May 9, 2018

Atlantic Healthcare Completes Phase 3 Trial Enrollment for Alicaforsen as Pouchitis Treatment

News

Atlantic Healthcare has completed enrollment for a Phase 3 trial evaluating the safety and efficacy of alicaforsen in patients with pouchitis, a frequent complication after surgery to treat different forms ... Read more

May 7, 2018May 7, 2018

Cellular Processes That May Be Target of Future IBD Therapies Revealed in Mouse Study

News

Cellular processes leading to the production of inflammatory cells in the gut may help explain the development of inflammatory bowel disease (IBD) and lead to new therapies, according to researchers. ... Read more

May 4, 2018May 4, 2018

Immunic Starts Enrollment in Phase 2 CALDOSE-1 Clinical Trial

News

The first patient has enrolled in the CALDOSE-1 phase 2 clinical trial, which seeks to determine whether Immunic AG‘s investigational drug IMU-838 can induce and maintain remission in patients with active ... Read more